logo-loader
viewMitre Medical

Mitre Medical gears up to treat heart disease patients in US-based study of its Mitral Touch device

Mitre Medical Corp CEO John MacMahon tells Proactive the privately-held group is developing a less invasive and safer approach to treat functional mitral valve regurgitation (MR) in patients with moderate to severe MR.

MacMahon says the group recently announced one-year results of the group's Mitral Touch in European patients, and looks forward to bringing the technology to the US within four different clinical sites.

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Anson Resources hails positive Novonix test results on its lithium samples

Anson Resources Ltd's (ASX:ASN) (FRA:9MY) Bruce Richardson speaks to Proactive's Andrew Scott soon after announcing positive results from initial test-work by Novonix Limited (ASX:NVX) (OTCQX:NVNXF) using lithium hydroxide and lithium carbonate bulk samples from the company’s flagship Paradox...

3 hours, 46 minutes ago

2 min read